Clinical Trial Data

The MammoSite Radiation Therapy System received FDA clearance in 2002.

The 5-year results of the initial MammoSite clinical trial⁷ involving 43 patients are now available, as is data from other studies.

• No local recurrences⁸
• 82% of patients had good/excellent cosmetic results⁹
• 100% of patients would recommend MammoSite Therapy to a friend or family member¹
• 100% of patients would use MammoSite Therapy again if they had to do it over¹

• Fifteen-month mean results (n=100)
  • 3.0% local recurrence rate (1 Elsewhere; 2 True Recurrence, Marginal Miss)
  • 95% of patients had good/excellent cosmetic results

NSABP-39

Prospective randomized trial of whole breast radiation therapy compared to partial breast radiation therapy.
Closed to low risk women as of December, 2006.

http://foundation.nsabp.org/schmeas/B39_info.htm